Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Progress report on access to hepatitis C treatment, WHO March 2018
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Asia Pacific Situational Updates on Generic DAAs – June 2017
